We evaluated the level of angiogenesis in endometrial adenocarcinoma and in
vestigated the relationship between tumor vascularity and clinicopathologic
al parameters. The level of angiogenesis in noninvaded uterine smooth muscl
e was also studied. Angiogenesis was studied in uteri of 29 post-menopausal
women operated on for endometrial cancer.
DAKO EPOS Anti-Human von Willebrand Factor/HRP antibodies were applied to m
ark endothelial cells. Both vessels and endothelial cells were counted on a
light microscope equipped with computerized morphometric appliance. The hi
ghest density of vessels and endothelial cells was found in disease-free ut
erine smooth muscle tissue situated distant to the tumor. Density of vessel
s and endothelial cell counts were higher in the outer as compared to the c
entral parts of the tumor. We found statistically significant differences i
n total angiogenic points' density between groups of various clinical FIGO
staging, specifically between Ia and Ib, Ic, II. A positive correlation was
found between the clinical stage of the disease (according to FIGO) and th
e total angiogenic points' density, density of endothelial cells and the de
nsity of vessels with viable lumen (counts/sq. mm calculated from the centr
al parts of the tumor). These results suggest that the analysis of angiogen
esis may be a useful biologic parameter and additional study of neovascular
ization in endometrial cancer is warranted.